Award
Award #75N93026D00012
Multi-Year IDV Contract for Antimicrobial Activity Research with University of Alabama
Buyer
National Institutes of Health
Award Amount
$2,500.00
Ceiling
$2,500.00
Awarded
September 30, 2026
Period of Performance
Sep 30, 2026 – Sep 29, 2036
Identifier
75N93026D00012
NAICS
541714
This award is a multi-year indefinite delivery vehicle (IDV) contract granted to the University of Alabama at Birmingham, a premier academic and research institution. The contract focuses on conducting in vitro assessments of antimicrobial activity, a critical area of study for health and pharmaceutical sectors. The agency gains specialized scientific evaluations that support public health initiatives and promote advancements in antimicrobial research. The scope encompasses extensive laboratory testing and analysis of various antimicrobial agents to evaluate their efficacy and safety. This competitively awarded, decade-long agreement ensures ongoing collaboration and a steady supply of valuable scientific services. No subcontractors or prior contracts were noted. This partnership significantly contributes to enhancing antimicrobial research capabilities.
Description
IN VITRO ASSESSMENT OF ANTIMICROBIAL ACTIVITY (IVAAA)